{"id":"W2902655481","doi":"10.1093/annonc/mdy518","title":"Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":631,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Metastatic breast cancer; Breast cancer; Triple-negative breast cancer; Cohort; Oncology; Clinical endpoint; Adverse effect; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001946586,0.001484954,0.001791664,0.0002590244,0.000617363,0.001425826,0.0008773107,0.001022776,0.003068881],"category_scores_gemma":[0.001280099,0.0006122202,0.001628288,0.0003671607,0.0006530434,0.001246709,0.0005011315,0.003093734,0.001384109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051017,"about_ca_system_score_gemma":0.001410852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001582118,"about_ca_topic_score_gemma":0.003251666,"domain_scores_codex":[0.9995269,0.0001953782,0.00002241123,0.00009790982,0.00004480454,0.0001126438],"domain_scores_gemma":[0.9992816,0.00009962269,0.0001634171,0.0001197312,0.00005217604,0.0002835051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8431635,0.02259162,0.03162047,0.0009975146,0.004672574,0.0003614887,0.0003004917,0.001860956,0.01760478,0.0004580378,0.01517424,0.0611943],"study_design_scores_gemma":[0.7127048,0.1669343,0.0933744,0.0001931425,0.004800205,0.0009412561,0.000323838,0.001446127,0.003091719,0.000814632,0.01527053,0.0001051148],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858887,0.002901873,0.000569276,0.0006258169,0.0001480201,0.001298076,0.00590874,0.0000615176,0.002598153],"genre_scores_gemma":[0.9762161,0.002952414,0.001379715,0.001526405,0.0003082339,0.001705709,0.01176626,0.00005345631,0.004091764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003068881,"threshold_uncertainty_score":0.01029462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05724842178695039,"score_gpt":0.4175517522361925,"score_spread":0.3603033304492421,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}